HHS Bars Use Of Federal Grants To Distribute Drug-Checking Test Strips
Health and Human Services has barred use of federal grants to distribute drug-checking test strips to the public in a late-April letter, a move advocates say could increase overdose deaths.[1]
The ban was issued in a late-April letter from the agency's Substance Abuse and Mental Health Services Administration.[1] It also forbids using Department of Health and Human Services grants to fund clean needles, drug paraphernalia such as pipes, or hotlines that monitor users while they take drugs.[1]
The department said the administration wants overdose-prevention funds focused on naloxone distribution and other approaches it calls "common-sense" and lawful.[1] Harm-reduction groups rely on free test strips to detect fentanyl, benzodiazepines, xylazine and other adulterants and say removing federal support could worsen overdose risks.[1]
Advocates warn the change could leave front-line programs without resources they say save lives.[1]
Show source details & analysis (1 source)
📌 Key Facts
- In late April 2026, SAMHSA sent a letter banning use of federal grants to distribute drug-checking test strips to the public.
- The policy also bars using Department of Health and Human Services grants to fund clean needles, drug paraphernalia such as pipes, or specialized hotlines that monitor users while they take drugs.
- An HHS spokesperson said the Trump administration wants overdose-prevention funds focused on naloxone distribution and other approaches it views as "common-sense" and lawful.
- Harm-reduction organizations report relying on free test strips to detect fentanyl, benzodiazepines, xylazine and other adulterants and fear the federal change will worsen overdose risks.
📰 Source Timeline (1)
Follow how coverage of this story developed over time